Suppr超能文献

癌症幸存者的避孕措施使用、临床实践及患者偏好

Contraception Use in Cancer Survivors, Clinical Practice and Patients' Preferences.

作者信息

Asinaro Giorgia, Stigliani Sara, Chiappe Edoardo, Lambertini Matteo, Massarotti Claudia

机构信息

IRCCS Ospedale Policlinico San Martino, Genova, Italy.

Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health (DINOGMI Department), School of Medicine, University of Genova, Genova, Italy.

出版信息

Open Access J Contracept. 2024 Dec 11;15:135-143. doi: 10.2147/OAJC.S431366. eCollection 2024.

Abstract

Current literature suggests that emergency contraception, defined as a therapy aimed at preventing an unwanted pregnancy after unprotected or insufficiently protected intercourse, is used more by cancer survivors than by the general population. This may be related to reduced use of contraception in women after cancer diagnosis and, when it is used, to a choice of less effective methods, even in the absence of contraindications to hormonal options. The purpose of this review is to analyze the use of contraception in these patients, its predictors and the preferred methods, as well as to try to define timing and characteristics of an effective contraception counseling. Factors identified as predictors of contraception usage were younger age, having a partner and better sexual function, having children, past use and having received contraception counseling by a gynecologist, especially in the previous year. Contraception counseling should start before oncological therapies, together with information regarding fertility and sexual health, preferably by the gynecologist of the oncofertility unit, with a specific expertise in dealing with cancer patients. Increased awareness of oncologists and family medicine doctors is fundamental to optimize contraception use and compliance with the prescribed method. Major guidelines regarding oncological care in women of fertile age already recommend contraception counseling, but optimal timing and mode of the consultation(s) options should be further researched, to be better detailed in all relevant documents.

摘要

当前文献表明,紧急避孕(定义为一种旨在防止无保护或保护不足的性交后意外怀孕的疗法)在癌症幸存者中的使用比在普通人群中更为普遍。这可能与癌症诊断后女性避孕措施使用减少有关,并且即使在没有激素避孕禁忌的情况下,她们在使用避孕措施时也会选择效果较差的方法。本综述的目的是分析这些患者的避孕措施使用情况、其预测因素和首选方法,以及试图确定有效避孕咨询的时机和特点。被确定为避孕措施使用预测因素的有:年龄较小、有伴侣且性功能较好、育有子女、过去曾使用过避孕措施以及曾接受妇科医生的避孕咨询,尤其是在前一年。避孕咨询应在肿瘤治疗前开始,同时提供有关生育能力和性健康的信息,最好由肿瘤生育科的妇科医生进行,他们在处理癌症患者方面具有专业特长。提高肿瘤学家和家庭医生的认识对于优化避孕措施的使用和遵守规定方法至关重要。关于育龄期女性肿瘤护理的主要指南已经建议进行避孕咨询,但咨询的最佳时机和方式应进一步研究,以便在所有相关文件中更详细地说明。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a311/11646390/694908643ce3/OAJC-15-135-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验